Gianluca Trifirò is MD, with post-graduate degree in Clinical Pharmacology (University of Messina, Italy), Master of Science in Clinical Epidemiology (NIHES, NL) and PhD in Clinical Pharmacology (University of Messina) and Pharmacoepidemiology (Erasmus Medical Center, Rotterdam, NL). He currently works as Full Professor of Pharmacology at the University of Verona and with honorary position at the Department of Medical informatics of the Erasmus Medical Center of Rotterdam. He is member of the Scientific Secretariat of postmarketing surveillance Office of the Italian Drug Agency and clinical pharmacologist of Phase I Clinical Trial Unit of Bambino Gesù Pediatric Hospital of Rome (Italy).
He is scientific coordinator of an Academic Master program on “Use of Real world data for evaluations in Pharmacovigilance, Pharmacoepidemiology and Pharmacoeconomics” at University of Verona and he is the scientific coordinator of the Italian Society of Pharmacology working group on pharmacoepidemiology and pharmacovigilance.
He has been active in the field of pharmacovigilance and pharmacoepidemiology since around 20 years and fully involved in the International Society of Pharmacoepidemiology (co-chair of mid-year meetings in Florence in 2011 and Rome in 2019, former BIOSIG chair). He is member of the steering group of the International Society of Pharmacovigilance and of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) of European Medicine Agency. He is member of advisory board of International society of Pharmacovigilance.
He is Field Chief Editor in Frontiers in Drug Safety and Regulation and member of Editorial Boards of Drug Safety, Pharmacoepidemiology and Drug Safety, Biodrugs, and Clinical Drug Investigation.
Authors of more than 200 publications on international scientific peer-reviewed journal.